Ron Leuty News & Views

Updated 3 months ago   More news & views
UCSF set to break ground on Global Health & Clinical Sciences Building at Mission Bay External-link
The University of California, San Francisco, is set to break ground Friday on its $94 million Global Health & Clinical Sciences Building at Mission Bay, which will also include the new office for UCSF Chancellor Susan Desmond-Hellmann. The research center, located across 16th Street from the new UCSF Medical Ce...
Comments Comment
Source: San Francisco Business...
Mar 21, 2013 - 9:33 AM
Browse Related Topics:   University ... San Francisco Ucsf Mission Bay
Allergen to buy Map Pharmaceuticals for $958M External-link
Allergan Inc. has agreed to buy Mountain View's Map Pharmaceuticals for $958 million, propelled by the expected Food and Drug Administration approval of Map's inhaled treatment for migraines. Allergan will snap up Map shares for $25 per share, a 60 percent premium. A treatment for migraines that was a joint project...
Comments Comment
Source: San Jose Business News...
Jan 23, 2013 - 1:47 PM
Browse Related Topics:   Food And Dr... Allergan Fda San Francis... More    
No place like home: Moscone expansion helps Bay Area biotech prospects External-link
San Francisco Business Times biotech reporter Ron Leuty is at the BIO convention in Boston this week. How local is this week’s Biotechnology Industry Organization convention in Boston? While riding the hotel elevator this morning, Reg Kelly, the director of QB3 at the University of California, San Francisco, stepp...
Comments Comment
Source: Business News from Sou...
Jun 18, 2012 - 7:44 AM
Browse Related Topics:   University ... Biotechnolo... Boston San Francisco More    
Genentech settles whistleblower suit External-link
Genentech Inc. has settled a whistleblower lawsuit for $29 million. As my colleague Ron Leuty at the San Francisco Business Times reports, the suit revolved around the off-lable marketing of the cancer-fighting drug Rituxan. While Genentech is based in San Francisco, its Oregon ties run deep. The biotech, a subsid...
Comments Comment
Source: Northwest U.S.
Dec 02, 2011 - 1:35 PM
Browse Related Topics:   San Francisco Oregon San Francis... Roche More    
IPierian gets back to drug discovery basics External-link
As a startup, iPierian boasted some of the world's top experts on stem cells. The impeccable scientific pedigree, however, never translated into the kind of partnering deals the biotech was looking for. And the lack of deals triggered turmoil at the helm. Now new CEO Nancy Stagliano tells San Francisco Business Time...
Comments Comment
Source: FierceMarkets
Sep 13, 2011 - 4:02 AM
Browse Related Topics:   Ips San Francis... Sfbt Nancy Stagl...
Slideshow: The Business Times' week in pictures External-link
In the September 2 issue of the San Francisco Business Times: Mark Dwight, CEO of Rickshaw Bagworks, and Chris Lindland, founder of Betabrand, both featured in Sarah Duxbury's story on SF Made and the organization's efforts to market San Francisco-based manufacturers. Eric Young's look at the Port of San Francisco...
Comments Comment
Source: San Francisco Business...
Sep 01, 2011 - 9:00 PM
Browse Related Topics:   America Business Times San Francis... Mike Depatie More    
Cancer drug developers rattled by widespread shortages External-link
Widely reported shortages of cancer drugs around the U.S. are triggering a bad case of anxiety among drug developers in the field. Reporting for the San Francisco Business Times, Ron Leuty found that developers are taking a variety of steps--including stockpiling--to ensure that they have the marketed drugs they nee...
Comments Comment
Source: FierceMarkets
Aug 16, 2011 - 2:12 AM
Browse Related Topics:   University ... Usa Today Abc News American So... More    
Leave a Comment about Ron Leuty

Cancel
Be the first to leave a comment!

Ron Leuty Videos